Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Stopped Study discontinued as DSMB determined it was futile. No safety concerns were noted.

Conditions

• BK Virus Infection
• Hemorrhagic Cystitis

Interventions

• BIOLOGICAL: Posoleucel (ALVR105)
• BIOLOGICAL: Placebo

Sponsor

AlloVir